Alveolar rhabdomyosarcoma associated with disseminated intravascular coagulation and a unique factor VIII antigen.
暂无分享,去创建一个
[1] J. Rodés,et al. Increased factor VIII complex and defective ristocetin-induced platelet aggregation in liver disease. , 1977, Thrombosis research.
[2] A. Eldor,et al. Alveolar rhabdomyosarcoma presenting as subacute intravascular coagulation. , 1977, Journal of clinical pathology.
[3] K. Denson. The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting. , 1977, Thrombosis research.
[4] J. Simeon,et al. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. , 1976, The Journal of laboratory and clinical medicine.
[5] D. Harkness,et al. In vivo and in vitro effects of thrombin and plasmin on human factor VIII (ahf) , 1976, American journal of hematology.
[6] T. Edgington,et al. Factor-VIII-related antigen: multiple molecular forms in human plasma. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[7] H. Weiss,et al. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. , 1973, The Journal of clinical investigation.
[8] Ruymann Fb,et al. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne). , 1971 .
[9] C. Merskey,et al. The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis , 1967, British journal of haematology.
[10] I. Ingram,et al. The determination of plasma fibrinogen by the clot-weight method. , 1952, The Biochemical journal.